EUVIMEDEUVIMED entdecken
VergleichsstudieMultizentrische StudieBeobachtungsstudie

Comparative Outcomes of Supera Interwoven Nitinol Versus Eluvia Fluoropolymer‐Based Drug‐Eluting Stents for the Treatment of Severely Calcified Femoropopliteal Artery Lesions: Results of the ELDORADO Study

Takashi Yanagiuchi iD, Takahiro Tokuda iD, Naoki Yoshioka iD, Shunsuke Kojima, Akiko Tanaka, Tatsuro Takei, Kenji Ogata, Kohei Yamaguchi, Tatsuya Nakama iD, Hirokazu Yokoi, LEADers PAD investigators

Catheterization and Cardiovascular Interventions · 2025

DOI: 10.1002/ccd.31409 ↗

Kurz gefasst

Vergleichsstudie in der Zeitschrift Catheterization and Cardiovascular Interventions, 2025. Verfasst von Takashi Yanagiuchi und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiology, Rakuwakai Otowa Hospital, Kyoto, Japan. Hauptthemen laut MEDLINE: Alloys, Drug-Eluting Stents, Endovascular Procedures, Femoral Artery. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 30 Literaturangaben. Gefördert von: The authors received no specific funding for this work..

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Supera interwoven nitinol stents (IWNS) and Eluvia fluoropolymer‐based drug‐eluting stents (DES) were designed to improve the patency of the femoropopliteal (FP) artery; however, which type of stent yields superior outcomes in calcified FP lesions remains unclear.

Aims

To compare the safety and efficacy of Supera IWNS and Eluvia DES in severely calcified FP lesions.

Methods

This study retrospectively analyzed 257 consecutive patients who underwent endovascular therapy using either IWNS ( n = 123) or DES ( n = 134) for FP lesions with peripheral arterial calcium scoring system (PACSS) grade 3 or 4 severe calcification between April 2018 and December 2021 at eight cardiovascular centers in Japan.

Results

Propensity score (PS) matching extracted 138 matched patients with no remarkable intergroup difference in patient and lesion characteristics. The 1‐year primary patency rates in the matched population were not significantly different between the IWNS and DES groups (85.4% vs. 89.8%, p = 0.320). A significant interaction between the stents used and the number of below‐the‐knee (BTK) runoff vessels was observed (interaction p = 0.048). The hazard ratio for restenosis was 2.68 (95% confidence interval, 0.51–14.2) in the group with no BTK runoff, favoring DES.

Conclusion

In PS‐matched patients with severely calcified FP lesions, 1‐year primary patency was not significantly different between treatments using Supera IWNS and Eluvia DES.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

AlloysDrug-Eluting StentsEndovascular ProceduresFemoral ArteryPeripheral Arterial DiseasePopliteal ArteryVascular CalcificationAgedAged, 80 and overFemaleHumansMaleMiddle AgedJapanProsthesis DesignRetrospective StudiesRisk AssessmentRisk FactorsSeverity of Illness IndexTime FactorsTreatment OutcomeVascular Patency

Stichwörter der Autor:innen

calcificationdrug‐eluting stentendovascular therapyfemoropopliteal segmentinterwoven stent

Substanzen

Alloysnitinol

Autor:innen und Institutionen

  • Department of Cardiology, Rakuwakai Otowa Hospital, Kyoto, Japan.
  • Department of Cardiology, Nagoya Heart Center, Nagoya, Japan.
  • Department of Cardiology, Ogaki Municipal Hospital, Ogaki, Japan.
  • Department of Cardiology, Tokyo Bay Urayasu Ichikawa Medical Center, Urayasu, Japan.
  • Department of Cardiology, Sendai Kousei Hospital, Sendai, Japan.
  • Department of Cardiology, Tenyoukai Central Hospital, Kagoshima, Japan.

ORCID-Profile: Takashi Yanagiuchi, Takahiro Tokuda, Naoki Yoshioka, Tatsuya Nakama

Förderung

  • The authors received no specific funding for this work.

Zitieren

APA

Yanagiuchi, T., Tokuda, T., Yoshioka, N., Kojima, S., Tanaka, A., Takei, T., Ogata, K., Yamaguchi, K., Nakama, T., Yokoi, H., & LEADers PAD investigators (2025). Comparative Outcomes of Supera Interwoven Nitinol Versus Eluvia Fluoropolymer‐Based Drug‐Eluting Stents for the Treatment of Severely Calcified Femoropopliteal Artery Lesions: Results of the ELDORADO Study. Catheterization and Cardiovascular Interventions. https://doi.org/10.1002/ccd.31409

Vancouver

Yanagiuchi T, Tokuda T, Yoshioka N, Kojima S, Tanaka A, Takei T, et al. Comparative Outcomes of Supera Interwoven Nitinol Versus Eluvia Fluoropolymer‐Based Drug‐Eluting Stents for the Treatment of Severely Calcified Femoropopliteal Artery Lesions: Results of the ELDORADO Study. Catheterization and Cardiovascular Interventions. 2025. doi:10.1002/ccd.31409

BibTeX
@article{Yanagiuchi2025,
  author = {Yanagiuchi, Takashi and Tokuda, Takahiro and Yoshioka, Naoki and Kojima, Shunsuke and Tanaka, Akiko and Takei, Tatsuro and Ogata, Kenji and Yamaguchi, Kohei and Nakama, Tatsuya and Yokoi, Hirokazu and LEADers PAD investigators, LEADers PAD investigators},
  title = {Comparative Outcomes of Supera Interwoven Nitinol Versus Eluvia Fluoropolymer‐Based Drug‐Eluting Stents for the Treatment of Severely Calcified Femoropopliteal Artery Lesions: Results of the ELDORADO Study},
  journal = {Catheterization and Cardiovascular Interventions},
  year = {2025},
  doi = {10.1002/ccd.31409}
}
Kostenlos starten →